Literature DB >> 15620967

The acute effects of transthoracic cryoablation on normal lung evaluated in a porcine model.

Yotaro Izumi1, Takahiko Oyama, Eiji Ikeda, Masafumi Kawamura, Koichi Kobayashi.   

Abstract

PURPOSE: Percutaneous transthoracic cryoablation of lung parenchymal tumors offers a potentially less invasive alternative to thoracoscopic tumor resection. In the present study, we investigated the feasibility of transthoracic cryoprobe insertion into the lung parenchyma. DESCRIPTION: Cryoablation was performed in porcine lung through a thoracotomy. A 2-mm diameter cryoprobe was inserted to a depth of 3 cm from the pleura. Cryoablation was performed as one or two cycles of 15-minute freeze followed by 5-minute thaw. Bleeding time and amount, and air leakage pressure from the insertion site was measured and compared between cycles. EVALUATION: The bleeding time and amount significantly increased, and air leakage pressure significantly decreased with two cycles of cryoablation compared with one cycle. Histologically, the primary finding in the cryolesion was localized pulmonary hemorrhage.
CONCLUSIONS: Bleeding time, bleeding amount, and air leakage from the insertion site after two cycles (453 +/- 202 s, 1.3 +/- 0.6 g, and 28 +/- 12 cm H2O, respectively) were considered unlikely to cause acute serious complications. Although long-term studies are needed, the present study provides support for transthoracic cryoablation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15620967     DOI: 10.1016/j.athoracsur.2003.09.082

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  13 in total

Review 1.  Alternative to surgery in early stage NSCLC-interventional radiologic approaches.

Authors:  Kyungmouk Steve Lee; Bradley B Pua
Journal:  Transl Lung Cancer Res       Date:  2013-10

2.  Clinical efficacy of percutaneous cryoablation combined with allogenic NK cell immunotherapy for advanced non-small cell lung cancer.

Authors:  Mao Lin; Shu-Zhen Liang; Xiao-Hua Wang; Ying-Qing Liang; Ming-Jie Zhang; Li-Zhi Niu; Ji-Bing Chen; Hai-Bo Li; Ke-Cheng Xu
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

3.  Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Authors:  Mao Lin; Shuzhen Liang; Xiaohua Wang; Yinqing Liang; Mingjie Zhang; Jibing Chen; Lizhi Niu; Kecheng Xu
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-04       Impact factor: 4.553

Review 4.  Decision Making in Interventional Oncology: Ablative Options in the Lung.

Authors:  Kyungmouk Steve Lee; Joseph P Erinjeri
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

Review 5.  Lung cancer ablation: technologies and techniques.

Authors:  Erica S Alexander; Damian E Dupuy
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

Review 6.  Imaging Features following Thermal Ablation of Lung Malignancies.

Authors:  Sophie Chheang; Feredoin Abtin; Antonio Guteirrez; Scott Genshaft; Robert Suh
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

7.  CT-guided percutaneous cryoablation of central lung tumors.

Authors:  Errol Colak; Servet Tatlı; Paul B Shyn; Kemal Tuncalı; Stuart G Silverman
Journal:  Diagn Interv Radiol       Date:  2014 Jul-Aug       Impact factor: 2.630

Review 8.  Experimental cryosurgery investigations in vivo.

Authors:  A A Gage; J M Baust; J G Baust
Journal:  Cryobiology       Date:  2009-10-13       Impact factor: 2.487

9.  Percutaneous cryoablation of pulmonary metastases from colorectal cancer.

Authors:  Yoshikane Yamauchi; Yotaro Izumi; Masafumi Kawamura; Seishi Nakatsuka; Hideki Yashiro; Norimasa Tsukada; Masanori Inoue; Keisuke Asakura; Hiroaki Nomori
Journal:  PLoS One       Date:  2011-11-09       Impact factor: 3.240

Review 10.  Cryoablation of early-stage primary lung cancer.

Authors:  Masanori Inoue; Seishi Nakatsuka; Masahiro Jinzaki
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.